Literature DB >> 17872925

Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation.

Nigel A Lever1, Emma G Newall, Peter D Larsen.   

Abstract

AIMS: The degree of organization of ventricular fibrillation (VF) can be examined in terms of the regularity of the electrical activity within the ventricle. Using electrograms (EGMs) stored within implanted cardioverter defibrillators (ICDs), we examined the hypothesis that the degree of organization, or regularity, was different if the VF was induced by electrical stimulation as opposed to occurring clinically due to ischemia or scar. METHODS AND
RESULTS: We compared the statistical characteristics of EGMs recorded by ICDs during spontaneous episodes with those induced during device testing in the laboratory in nine subjects. Regularity of the VF EGM signals was quantified using autocorrelation, Shannon entropy (derived from cycle to cycle activation complexes), and Kolmogorov entropy (derived from eight second long episodes of VF). All three measurements showed a statistically greater degree of regularity for induced VF than in spontaneous episodes.
CONCLUSION: Analysis of VF EGMs using these techniques is novel and robust, providing a new way for assessing electrical organization during VF. The clinical significance and utility of differences in VF waveform regularity is unclear at this stage.

Entities:  

Mesh:

Year:  2007        PMID: 17872925     DOI: 10.1093/europace/eum194

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  [Is intraoperative ICD-testing still necessary?].

Authors:  C Mewis; H-R Neuberger; A Buob
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

2.  Ventricular Fibrillation Waveform Analysis During Chest Compressions to Predict Survival From Cardiac Arrest.

Authors:  Jason Coult; Jennifer Blackwood; Lawrence Sherman; Thomas D Rea; Peter J Kudenchuk; Heemun Kwok
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-01

3.  Shock or no shock - a question of philosophy or should intraoperative implantable cardioverter defibrillator testing be recommended?

Authors:  Andreas Keyser; Michael K Hilker; Sebastian Schmidt; Christian von Bary; Wolfgang Zink; Michael Ried; Christof Schmid; Claudius Diez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-07

4.  Underdetection of ventricular fibrillation despite ICD testing and high sinus R wave.

Authors:  Dirk Bastian
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-06-20

5.  Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.

Authors:  Eran Leshem; Mahmoud Suleiman; Avishag Laish-Farkash; Yuval Konstantino; Michael Glikson; Alon Barsheshet; Ilan Goldenberg; Yoav Michowitz
Journal:  Europace       Date:  2017-09-01       Impact factor: 5.214

6.  Tachyarrhythmia Cycle Length in Appropriate versus Inappropriate Defibrillator Shocks in Brugada Syndrome, Early Repolarization Syndrome, or Idiopathic Ventricular Fibrillation.

Authors:  Woo Seok Lee; Jun Kim; Chang-Hee Kwon; Jin Hee Choi; Uk Jo; Yoo Ri Kim; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

7.  Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation.

Authors:  Susumu Tao; Samuel F Way; Joshua Garland; Jonathan Chrispin; Luisa A Ciuffo; Muhammad A Balouch; Saman Nazarian; David D Spragg; Joseph E Marine; Ronald D Berger; Hugh Calkins; Hiroshi Ashikaga
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

8.  Computerized Analysis of the Ventricular Fibrillation Waveform Allows Identification of Myocardial Infarction: A Proof-of-Concept Study for Smart Defibrillator Applications in Cardiac Arrest.

Authors:  Jos Thannhauser; Joris Nas; Dennis J Rebergen; Sjoerd W Westra; Joep L R M Smeets; Niels Van Royen; Judith L Bonnes; Marc A Brouwer
Journal:  J Am Heart Assoc       Date:  2020-10-02       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.